DESTINATION: TEZEPELUMAB LONG-TERM SAFETY AND EFFICACY VERSUS PLACEBO IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA

被引：1
|
作者：
Menzies-Gow, A. [1 ]
Wechsler, M. E. [2 ]
Brightling, C. E. [3 ]
Korn, S. [4 ,5 ]
Bednarczyk, A. [6 ]
Ponnarambil, S. [7 ]
Almqvist, G. [8 ]
Lawson, K. [9 ,10 ]
Caveney, S. [11 ]
Bowen, K. [12 ]
Colice, G. [9 ]
机构：
[1] Royal Brompton & Harefield Hosp, London, England
[2] Natl Jewish Hlth, Denver, CO USA
[3] Univ Leicester, Inst Lung Hlth, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England
[4] IKF Pneumol Mainz, Mainz, Germany
[5] Thoraxklin Heidelberg, Heidelberg, Germany
[6] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Warsaw, Poland
[7] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Cambridge, England
[8] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Gothenburg, Sweden
[9] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Gaithersburg, MD USA
[10] Cytel Inc, Cambridge, MA USA
[11] Amgen Inc, Global Dev, R&D, Thousand Oaks, CA USA
[12] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Biometr, Gaithersburg, MD USA
来源：
THORAX | 2022年 / 77卷
关键词：
D O I：
10.1136/thorax-2022-BTSabstracts.53
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S47
引用
收藏
页码：A32 / A32
页数：1
相关论文
共 50 条
  • [21] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
    Menzies-Gow, Andrew
    Corren, Jonathan
    Israel, Elliot
    Welte, Tobias
    Ambrose, Christopher S.
    Cook, Bill
    Hunter, Gillian
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [22] DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Menzies-Gow, Andrew
    Ponnarambil, Sandhia
    Downie, John
    Bowen, Karin
    Hellqvist, Asa
    Colice, Gene
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [23] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY BASELINE BMI IN THE NAVIGATOR STUDY
    Chupp, Geoffrey
    Menzies-Gow, Andrew
    Ambrose, Christopher
    Cook, William
    Kmita, Kamil
    Lindsley, Andrew
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    Lugogo, Njira
    CHEST, 2021, 160 (04) : 37A - 40A
  • [24] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND HIGH BASELINE BLOOD EOSINOPHIL COUNTS
    Jain, N.
    Llanos-Ackert, J.
    Ambrose, C.
    Cook, B.
    Ponnarambil, S.
    Martin, N.
    Webb, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S36 - S37
  • [25] On-treatment clinical remission with tezepelumab in patients with severe, uncontrolled asthma in the phase 3 DESTINATION study
    Wechsler, Michael E.
    Brusselle, Guy
    Virchow, J. Christian
    Heaney, Liam G.
    Hunter, Gillian
    Ponnarambil, Sandhia
    Martin, Neil
    Llanos, Jean-Pierre
    Porsbjerg, Celeste
    Brightling, Christopher E.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [26] ON-TREATMENT CLINICAL REMISSION WITH TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN THE PHASE 3 DESTINATION STUDY
    Wechsler, M. E.
    Brusselle, G.
    Virchow, J. C.
    Heaney, L. G.
    Hunter, G.
    Ponnarambil, S.
    Martin, N.
    Llanos, J-P
    Porsbjerg, C.
    Brightling, C. E.
    THORAX, 2023, 78 (SUPPL_4) : A272 - A273
  • [27] TEZEPELUMAB EFFICACY IN PATIENTS WITH SEVERE ASTHMA BY BLOOD EOSINOPHIL COUNT AND PERENNIAL ALLERGY (DESTINATION)
    Wechsler, M.
    Carr, T.
    Ponnarambil, S.
    Li, T.
    Caveney, S.
    Llanos-Ackert, J.
    Martin, N.
    Corren, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S45 - S45
  • [28] LONG-TERM EFFICACY OF OMALIZUMAB IN PATIENTS WITH SEVERE ASTHMA
    Saji, J.
    Yamamoto, T.
    Arai, M.
    Mineshita, M.
    Miyazawa, T.
    RESPIROLOGY, 2014, 19 : 7 - 7
  • [29] THE LONG-TERM SAFETY AND EFFICACY OF TULOBUTEROL IN PATIENTS WITH ASTHMA
    PATEL, KR
    KERR, JW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (01) : 200 - 200
  • [30] Long-term efficacy and safety for 6 severe asthma patients after bronchial thermoplasty
    Handa, Hiroshi
    Ishida, Kasuo
    Nishi, Yoshihiro
    Tsuruoka, Hajime
    Morikawa, Kei
    Nishine, Hiroki
    Mineshita, Masamichi
    RESPIROLOGY, 2023, 28 : 331 - 332
12345